🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Pre op ultrasound with chest auscultation and arterial blood gas, after ext...
Status
Completed
Location
Multiple Locations
Start Date
2016-11-01
Trial ID
NCT03144310
Treatments Being Tested
RATIONALE: Studying samples of blood from patients with cancer in the labor...
Status
Completed
Location
Multiple Locations
Start Date
2003-09
Trial ID
NCT00899210
The proposed research program will investigate the changes in brain chemist...
Status
Completed
Location
Connecticut Mental Health Center
Start Date
2018-02-26
Trial ID
NCT03471182
This randomized phase I trial is studying the side effects, such as high bl...
Status
Terminated
Location
University of Chicago
Start Date
2007-01
Trial ID
NCT00436579
RATIONALE: Collecting and storing samples of tumor tissue from patients wit...
Status
Completed
Location
Knight Cancer Institute at Oregon Health and Science University
Start Date
2005-08
Trial ID
NCT00899522
Treatments Being Tested
COPE is a biology driven protocol with 2 independent, multicentric, two-arm...
Status
Active Not Recruiting
Location
Centre hospitalier de la Côte Basque
Start Date
2020-09-04
Trial ID
NCT04258137
Treatments Being Tested
The study is an open label single centre randomised cross over study to eva...
Status
Completed
Location
Clinique des Enfants CHluxembourg
Start Date
2017-02-23
Trial ID
NCT03103867
Treatments Being Tested
Evaluation of the diagnostic performance of exome sequencing in a prospecti...
Status
Completed
Location
DRCI
Start Date
2019-06-12
Trial ID
NCT04043351
Treatments Being Tested
This phase I/II trial studies the side effects and best dose of auranofin w...
Status
Completed
Location
Mayo Clinic in Arizona
Start Date
2014-05-14
Trial ID
NCT01737502
Treatments Being Tested
The study aims to develop PRIME (PRostate cancer plasma Integrative Multi-m...
Status
Recruiting
Location
Istituto Romagnolo per lo Studio dei Tumori
Start Date
2019-05-07
Trial ID
NCT06981377